The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Texas, issued a diagnosis for America's broken health care system, and he says the problem isn't what people think.

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...